Suven Pharmaceuticals Limited - Company Profile

It is a pharma public limited company based in Hyderabad, Telangana, India, established in 2018.

2018 Hyderabad, Telangana, India Active

Last Updated: February 15, 2022

About Suven Pharmaceuticals Limited

Suven Pharmaceuticals Limited, a active public limited company, was established on 06 November 2018 in Hyderabad, Telangana, India. Engaging in pharmaceutical formulations within the manufacturing sector, it holds CIN: U24299TG2018PLC128171. Registered under ROC Roc-Hyderabad. it is listed on BSE: 543064 and NSE: SUVENPHAR. It has an authorized capital of ₹40.00 Cr and a paid-up capital of ₹25.46 Cr.

In 2022, it reported revenue of ₹1,508.01 Cr and a net worth of ₹1,520.69 Cr. Employing 943 professional, Its leadership includes Jerry Jeyasingh (Director). Past directors included Venkateswarlu Jasti. It holds ₹174.02 Cr open charges and no settled loans. Its latest AGM occurred on 31 August 2021, with the balance sheet filed on 31 March 2021. It is based at # 8-2-334, Sde Serene Chambers, 3Rd Floor, Avenue 7, Road No. 5, Banjara Hills, Hyderabad, Telangana, 500034.

Company Details

CIN/LLPIN
U24299TG2018PLC128171
Registration Number
128171
Incorporation Date
06 November 2018
Authorized Capital
₹40.00 Cr
Paid-Up Capital
₹25.46 Cr
ROC Code
Roc-Hyderabad
Listing Status
Listed (BSE: 543064, NSE: SUVENPHAR)
Company Status
Active

Key Metrics

Authorised Capital ₹ 40.00 Cr as on 15-02-2022
Paid Up Capital ₹ 25.46 Cr as on 15-02-2022
Company Age 7 Year, 4 Months
Last Filing with ROC 31 Mar 2021
Open Charges ₹ 174.02 Cr as on 15-02-2022
Revenue Growth **** 47.27% (FY 2022)
Profit Growth **** 80.82% (FY 2022)
Ebitda **** 59.62% (FY 2022)
Net Worth 42.76% (FY 2022)
Total Assets **** 32.56% (FY 2022)

Comprehensive Company Insights

Explore comprehensive insights into Suven Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Suven Pharmaceuticals Limited?

Current Directors

Name	Designation	Appointment Date	Status
Jerry Jeyasingh	Director	06 Nov 2019	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Chief Executive Officer	-	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Suven Pharmaceuticals.

Suven Pharmaceuticals Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 47.27% increase. The company also saw a substantial improvement in profitability, with a 80.82% increase in profit. The company's net worth Soared by an impressive increase of 42.76%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

47.27%

*******

Revenue from Operations

*******

30.75%

*******

Total Assets

*******

32.56%

*******

Profit or Loss

*******

80.82%

*******

Net Worth

*******

42.76%

*******

EBITDA

*******

59.62%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Suven Pharmaceuticals?

In 2021, Suven Pharmaceuticals had a promoter holding of 60.00% and a public holding of 40.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹1,740,200,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

State Bank Of India : 164.02 Cr
Bank Of Bahrain And Kuwait Bsc : 10.00 Cr

Latest Charge Details

Date	Lender	Amount	Status
29 Dec 2020	Bank Of Bahrain And Kuwait Bsc	₹10.00 Cr	Open
05 Nov 2020	State Bank Of India	₹164.02 Cr	Open

Explore comprehensive loan charge details -

How Many Employees Work at Suven Pharmaceuticals?

Suven Pharmaceuticals has a workforce of 877 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Suven Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Suven Pharmaceuticals's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Suven Pharmaceuticals

Recent Activity within the Organization

Annual General Meeting

The activity Suven Pharmaceuticals Limited last Annual general meeting of members was held on 31 Aug 2021 as per latest MCA records. was completed.
31 Aug 2021
Balance Sheet

The activity Suven Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with RoC-Hyderabad. was completed.
31 Mar 2021
Charges

The activity A charge with Bank Of Bahrain And Kuwait Bsc amounted to Rs. 10.00 Cr with Charge ID 100402459 was registered on 29 Dec 2020. was completed.
29 Dec 2020
Charges

Progress on A charge with State Bank Of India of Rs. 164.02 Cr registered on 05 Nov 2020 with Charge ID 100391471 was modified on 28 Dec 2020. was documented.
28 Dec 2020
Charges

A charge with State Bank Of India amounted to Rs. 164.02 Cr with Charge ID 100391471 was registered on 05 Nov 2020. was recorded as a recent event.
05 Nov 2020
Director Appointment

The activity Hanumantha Rao Kokkonda was appointed as a Company Secretary was appointed as a Company Secretary on 10 Jan 2020 & has been associated with this company since 6 years 2 months . was completed.
10 Jan 2020

Explore recent activity and updates - View Recent Activity